UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040508
Receipt number R000046243
Scientific Title Survey on bowel preparation for colonoscopy
Date of disclosure of the study information 2020/06/01
Last modified on 2021/04/13 13:08:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Survey on bowel preparation for colonoscopy

Acronym

Survey on bowel preparation for colonoscopy

Scientific Title

Survey on bowel preparation for colonoscopy

Scientific Title:Acronym

Survey on bowel preparation for colonoscopy

Region

Japan


Condition

Condition

Patients scheduled for colonoscopy

Classification by specialty

Gastroenterology Gastrointestinal surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To obtain evidence for a bowel preparation agent that meets the needs of our customers, in order to clarify what is important in pretreatment of colonoscopy for medical professionals (physicians, nurses, technicians) by questionnaire surveys on the Web.

Basic objectives2

Others

Basic objectives -Others

Fact-finding survey

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Importance scores of bowel preparation for colonoscopy by items.

Key secondary outcomes

Differences between occupations (physicians/nurses/technicians) on the importance score of bowel preparation for colonoscopy by item.

Differences by facility and respondent background on the importance score of bowel preparation for colonoscopy by item.

Aggregation of confirmation items before inspection.

Aggregation of defecation management before inspection.

Aggregation of evaluation of bowel preparation in use.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

- Physicians, nurses, and technicians performing colonoscopies
- Currently working at a facility that performs more than 20 colonoscopies per month

Key exclusion criteria

No specific settings

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Hisanori
Middle name
Last name Masaki

Organization

EA Pharma Co., Ltd.

Division name

Associate General Manager (Medical Department)

Zip code

104-0042

Address

2-1-1, Irifune, Chuo-ku, Tokyo 104-0042, Japan

TEL

03-6280-9685

Email

hisanori_masaki@eapharma.co.jp


Public contact

Name of contact person

1st name Hisanori
Middle name
Last name Masaki

Organization

EA Pharma Co., Ltd.

Division name

Associate General Manager (Medical Department)

Zip code

104-0042

Address

2-1-1, Irifune, Chuo-ku, Tokyo 104-0042, Japan

TEL

03-6280-9685

Homepage URL


Email

hisanori_masaki@eapharma.co.jp


Sponsor or person

Institute

EA Pharma Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

EA Pharma Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamauchi Clinic IRB

Address

1-15-19, Jiyugaoka, Meguro Ku, Tokyo To, Japan

Tel

03-5575-5862

Email

c-irb_ug@neues.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

330

Results

All medical doctors and approximately 90% of nurses and technicians understood the risk of using a lavage solution. Interviews using patient information were conducted in almost 100% of either occupation. However, the answer that a corresponding manual had been created varied among occupations. In particular, 40% of medical doctors and 20% of nurses and technicians answered that they have no corresponding manual for patients who were taking lavage solution at home.

Results date posted

2021 Year 04 Month 13 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 05 Month 22 Day

Date of IRB

2020 Year 05 Month 22 Day

Anticipated trial start date

2020 Year 06 Month 19 Day

Last follow-up date

2020 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

nothing


Management information

Registered date

2020 Year 05 Month 25 Day

Last modified on

2021 Year 04 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046243


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name